drugset / Trial / NCT06187493
Treatment of Patients With Diabetic Kidney Disease
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Due to irrespective of the limitations associated with estimated glomerular filtration rate (eGFR), it is crucial to develop new treatments that can effectively address these concerns. So, this study aimed to compare the effectiveness of SGlT2i versus ACEi in the progression of diabetic kidney disease including progression of albuminuria. Doubling of serum creatinine and need for renal replacement therapy
Timeline
- Start
- 2024-01-01
- Primary completion
- 2025-01-31
- Completion
- 2025-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dapagliflozin | Small molecule | — | — |
| Subject | Empagliflozin | Small molecule | — | — |
| Subject | Enalapril | Other / unclassified | — | — |
| Subject | LISINOPRIL ANHYDROUS | Small molecule | — | — |